Trevena Inc
F:6T40
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Trevena Inc
F:6T40
|
US |
|
W
|
Western Digital Corp
XBER:WDC
|
US |
|
Y
|
Ypsomed Holding AG
XBER:OWX
|
CH |
|
J
|
JD.Com Inc
VSE:JD
|
CN |
|
R
|
Ryman Healthcare Ltd
F:RH7
|
NZ |
|
A
|
Arbor Realty Trust Inc
XMUN:OWQ
|
US |
|
Hexpol AB
OTC:HXPLF
|
SE |
|
A
|
AGNC Investment Corp
F:4OQ1
|
US |
|
Dentsu Group Inc
F:DEN
|
JP |
|
Grupo Simec SAB de CV
F:GSM
|
MX |
|
O
|
OPKO Health Inc
BMV:OPK
|
US |
|
B
|
Barrick Gold Corp
XMUN:ABR
|
CA |
|
E
|
Envoy Medical Inc
NASDAQ:COCH
|
US |
|
Wereldhave Belgium NV
F:WPU
|
BE |
|
Trigano SA
OTC:TGNOF
|
FR |
|
S
|
Swiss Re AG
OTC:SSREF
|
CH |
|
VGP NV
OTC:VGPBF
|
BE |
|
National Bankshares Inc
F:9F2
|
US |
|
Lattice Semiconductor Corp
NASDAQ:LSCC
|
US |
|
S
|
Silvercorp Metals Inc
DUS:S9Y
|
CA |
|
Uniqa Insurance Group AG
F:UN9
|
AT |
|
T
|
TransDigm Group Inc
LSE:0REK
|
US |
Bankruptcy Probability
Trevena Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Trevena Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Trevena Inc
NASDAQ:TRVN
|
9.4k USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
356.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
178B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
165.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
109.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
75.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
42.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
57.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Trevena Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Trevena Inc has total debt of 32m USD. This includes both short-term (0 USD) and long-term (32m USD) debt.
You can find a full breakdown on its Balance Sheet.
